Zdrowie i gospodarka · 24/02/2005

FDA Releases Guidance for Medical Device Manufacturers on Using Cadaveric Blood Specimens for Communicable Disease Screening

The FDA has made available a document providing recommendations for medical device manufacturers to modify the indication for use of communicable disease tests to include testing of cadaveric blood specimens from donors of human cells, tissues, and cellular and tissue-based products, as outlined in the 2004 guidance document